Moleculin Biotech, Inc. (MBRX) News

Latest headlines that mention MBRX, newest first · each headline opens the original publisher

MBRX quote

Last price: $7.08
Day change: +9.00%
Next earnings: 2026-11-12

Quote & chart Expected move Insider trading IV rank history

MBRX headlines

latest coverage

Seeking Alpha 10d ago

Moleculin announces 1-for-20 reverse stock split, shares slide

General T2MBRX

Investing.com 27d ago

Moleculin completes enrollment in Annamycin AML trial Part A

General T3MBRX

Investing.com 1mo ago

Moleculin presents preclinical pancreatic cancer data at AACR

General T3MBRX

Investing.com 1mo ago

Moleculin Biotech receives Nasdaq delisting notice after minimum bid price violation

Markets T3MBRX

Seeking Alpha 2mo ago

Moleculin Biotech GAAP EPS of -$1.40 misses by $0.53

Earnings T2MBRX

Investing.com 2mo ago

Moleculin reports blinded remission data from leukemia trial

General T3MBRX

Investing.com 4mo ago

Form 4 Moleculin Biotech Inc For: 24 June

General T3MBRX

Seeking Alpha 5mo ago

Moleculin Biotech GAAP EPS of -$3.54 misses by $2.08

Earnings T2MBRX

Investing.com 5mo ago

Moleculin Biotech secures Hong Kong patent for Annamycin

General T3MBRX

MBRX news alerts

Get an alert by email or push when a new headline mentions MBRX.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.